0001628280-18-012281.txt : 20181003
0001628280-18-012281.hdr.sgml : 20181003
20181003180316
ACCESSION NUMBER: 0001628280-18-012281
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181003
FILED AS OF DATE: 20181003
DATE AS OF CHANGE: 20181003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TLS Beta Pte. Ltd.
CENTRAL INDEX KEY: 0001673754
STATE OF INCORPORATION: U0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 181106347
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65-6828-6828
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temasek Life Sciences Private Ltd
CENTRAL INDEX KEY: 0001379349
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 181106348
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 0116568286762
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
FORMER NAME:
FORMER CONFORMED NAME: Temasek Life Sciences Private LTD
DATE OF NAME CHANGE: 20061027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fullerton Management Pte Ltd
CENTRAL INDEX KEY: 0001379348
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 181106349
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65 6828 6586
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temasek Holdings (Private) Ltd
CENTRAL INDEX KEY: 0001021944
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 181106350
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65 6828 6828
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
FORMER NAME:
FORMER CONFORMED NAME: TEMASEK HOLDINGS (PRIVATE) LTD
DATE OF NAME CHANGE: 20050912
FORMER NAME:
FORMER CONFORMED NAME: TEMASEK HOLDINGS LTD
DATE OF NAME CHANGE: 19960829
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
3
1
wf-form3_153860417616313.xml
FORM 3
X0206
3
2018-10-03
0
0001576280
Guardant Health, Inc.
GH
0001673754
TLS Beta Pte. Ltd.
60B ORCHARD ROAD #06-18
TOWER 2 THE ATRIUM@ORCHARD
SINGAPORE
238891
0
0
1
0
0001379349
Temasek Life Sciences Private Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
238891
0
0
1
0
0001379348
Fullerton Management Pte Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
238891
0
0
1
0
0001021944
Temasek Holdings (Private) Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
238891
0
0
1
0
SERIES D PREFERRED STOCK
COMMON STOCK
1016995.0
I
By TLS Beta Pte. Ltd.
SERIES E PREFERRED STOCK
COMMON STOCK
596012.0
I
By TLS Beta Pte. Ltd.
The shares of the Issuer's Series D and Series E Preferred Stock (collectively, the "Preferred Stock) are convertible, at the option of the holder, into shares of Common Stock at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). The shares of Preferred Stock will automatically convert into shares of the Issuer's Common Stock, for no additional consideration, at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Certificate of Incorporation) immediately prior to the consummation of the Issuer's initial public offering, and have no expiration date.
The shares are directly held by TLS Beta Pte. Ltd., which is a direct wholly-owned subsidiary of Temasek Life Sciences Private Limited. Temasek Life Sciences Private Limited is a direct wholly-owned subsidiary of Fullerton Management Pte Ltd, or FMPL, which in turn is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited. Temasek Life Sciences Private Limited, FMPL and Temasek Holdings (Private) Limited may therefore be deemed to have or share beneficial ownership of the securities held by TLS Beta Pte. Ltd. Each Reporting Person disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
TLS Beta Pte Ltd., /s/Christina Choo Soo Shen, Director
2018-10-03
Temasek life Sciences Private Limited, /s/Lim Siew Lee Sherlyn, Director
2018-10-03
Fullerton Management Pte. Ltd., /s/Cheong Kok Tim, Director
2018-10-03
Temasek Holdings (Private) Limited, /s/Christina Choo Soo Shen, Authorized signatory
2018-10-03